Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome
Ημερομηνία
1999Λέξη-κλειδί
Επιτομή
Recent clinical studies have suggested that women with polycystic ovarian syndrome (PCOS) may have disturbances of growth hormone (GH) kinetics and the GH/insulin-like growth factor (IGF)-I system. The knowledge that in various metabolic abnormalities there is a paradoxical sensitivity of pituitary somatotrophs to thyrotrophin-releasing hormone (TRH) administration led to this investigation of the GH secretory response to TRH in women with PCOS, Twenty-four women with PCOS and 18 control women were studied. TRH was given as a single i.v. injection (time 0) and blood samples for GH measurements were obtained at -15, 0, 15, 30, 60 and 90 min. The GH responses were expressed as the area under the curve (AUC) or the differences from the basal value (Delta max), The GH response to TRH(mean +/- SEM) was greater in women with PCOS (Delta max 2.47 +/- 1.73 versus 0.47 +/- 0.06 ng/ml, P < 0.05 and GH AUC 8.05 +/- 2.10 versus 2.58 +/- 0.18 ng/ ml/90 min, P < 0.05), According to GH response to TRH, two PCOS subgroups were identified: (i) normal responders (n = 14) who showed Delta max GH response (0.36 +/- 0.06 ng/ml)and GH AUC (1.93 +/- 0.64 ng/ml/90 min) similar to that in the controls and (ii) over-responders (n +/- 10) who showed a paradoxical increase in GH concentrations in response to TRH Delta max GH response 5.43 +/- 1.27 ng/ml and GH AUC 16.62 +/- 3.51 ng/ml per 90 min) that was significantly higher than in normally responding PCOS patients (P < 0.0001) or in controls (P < 0.0001), These data demonstrate an enhanced GH response to TRH administration in a subgroup of women with PCOS.
Collections
Related items
Showing items related by title, author, creator and subject.
-
The effect of a GnRH antagonist on follicle maturation in normal women
Pousias S., Messini C.I., Anifandis G., Sveronis G., Georgoulias P., Daponte A., Messinis I.E., Dafopoulos K. (2019)Research question: Ganirelix is a gonadotrophin-releasing hormone (GnRH) antagonist used for the prevention of premature LH surge during ovarian stimulation. What is the impact of ganirelix on follicle maturation in normal ... -
Biology of the steroid hormone receptor superfamily
Vamvakopoulos, N. C. (1996)Following a brief introduction to the Biology (structure-function) of the steroid hormone receptor superfamily, an updated summary of pathogenic mutations in the steroid, thyroid hormone and vitamin D receptors causing ... -
Ghrelin suppresses the GnRH-induced preovulatory gonadotropin surge in dairy heifers
Chouzouris T.M., Dovolou E., Dafopoulos K., Georgoulias P., Vasileiou N.G., Fthenakis G.C., Anifandis G., Amiridis G.S. (2016)Ghrelin, a known growth hormone (GH) secretagogue, alters gonadotropin secretion in many species. Our objectives were to study the effects of ghrelin, on GH, LH, FSH secretion, and on luteal function of the ensuing estrous ...